SOPHiA GENETICS

Public

Saint Sulpice, VaudHealthcarehttps://www.sophiagenetics.com

Last Round

Private Placement

Jul 27, 2021

Est. Valuation

$1.14B

Total Funding Raised

$502.55M

Company Overview

SOPHiA GENETICS is a healthcare technology company that provides a cloud-native SaaS platform, SOPHiA DDM™, dedicated to advancing data-driven medicine. The platform utilizes AI and machine learning to analyze complex multimodal data sets, including genomic and radiomic data, to generate actionable insights for healthcare providers, laboratories, and biopharmaceutical institutions. Founded in 2011 as a startup from the École Polytechnique Fédérale de Lausanne (EPFL), the company aims to democratize precision medicine for oncology, rare diseases, cardiology, and other conditions. By connecting a global network of institutions, the platform fosters collective intelligence while allowing users to maintain control of their data. SOPHiA GENETICS went public in July 2021 and is traded on the Nasdaq (SOPH). The company serves customers in over 70 countries and has dual headquarters in Rolle, Switzerland, and Boston, USA.

Sector

Healthcare

AI Layer

Application

Keywords

data-driven medicine platformcloud-native healthcare SaaS platformgenomic and radiomic data analysisAI for oncology and rare disease diagnosticsdecentralized clinical data analysismultimodal health data analysisusage-based billing for genomic analysisliquid biopsy analysis applicationclinical research analytics platformbiopharma drug development platformcompanion diagnostics development support

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

SOPHiA GENETICS Comps

Public and private peers based on sector, stage, and business model.

Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

SOPHiA GENETICS Funding Rounds

Historical fundraising activity

Round	Date	Amount Raised	Valuation	Investors	Sources
Private Placement	Jul 27, 2021
IPO Announced	Jul 22, 2021
Series F	Oct 1, 2020
Series E	Jan 4, 2019
Series D	Sep 13, 2017
Series C	Dec 16, 2015

View all Funding Rounds

Key People

Founding team and executive leadership

Philippe Menu

EVP, Chief Product Officer and Chief Medical Officer

Executive Team

Zhenyu Xu

Chief Scientific Officer

Executive Team

SOPHiA GENETICS Investors

Notable investors and investment history

Investor	Rounds
360 Capital	Series D
Pictet Group	Series F
Idinvest Partners	Series E
Swisscom Ventures	Series F
HV Fund	Series F
360 Capital	Series D
Al-Nahdi	Series F

View all Investors

SOPHiA GENETICS Filings

SEC and related filings with document metadata.

Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

SOPHiA GENETICS Filings

SEC and related filings with document metadata.

Firmographic Details

HeadquartersSaint Sulpice, Vaud

Employee Range519

Year Founded2011

Last FundingJul 27, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.